High-intensity ultrasound helps curb prostate
Ablation using high-intensity focused ultrasound can effectively control some types of localized prostate cancer for five years or longer, according to a study by German researchers.
Ablation using high-intensity focused ultrasound can effectively control some types of localized prostate cancer for five years or longer, according to a study by German researchers.
Dr. Andreas Blana and colleagues at the University of Regensburg's St. Josef Hospital evaluated results from 140 patients with early or intermediate localized prostate cancer who underwent treatment across
Europe between 1997 and 2001. Follow-up prostate biopsies were negative in 86.4% of patients who underwent focused ultrasound ablation, with a five-year PSA-related failure-free survival rate of 77%. The overall disease-free rate at five and seven years was 66% and 59%, respectively. Findings were published online Nov. 5 in European Urology.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
